IDEXX Laboratories (IDXX)
IDEXX Laboratories Revenues: 322.68M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
IDXX Revenues Rankings
| Overall | 67th percentile | 1429 of 4425 |
| Sector | 79th percentile | 97 of 470 in Healthcare |
| Industry | 94th percentile | 1 of 17 in Diagnostic Substances |
IDXX Revenues Range, Past 5 Years
| Minimum | 229.38M | Sep 2007 |
| Maximum | 322.68M | Mar 2012 |
| Average | 270.59M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these IDXX related companies
IDXX News
$IDXX - Trailing Stop hit. Trade closed @ $82.56 - http://stks.co/3vBQ
about 9 days ago by TraderFoxxx
about 9 days ago by TraderFoxxx
$IDXX forms bearish "Diamond Top" chart pattern. http://stks.co/3p61
about 15 days ago by RecogniaEvents
about 15 days ago by RecogniaEvents
IDEXX Laboratories' CEO Hosts Annual Shareholder Meeting Conference (Transcript)
May 09, 3:37PM Seeking Alpha
May 09, 3:37PM Seeking Alpha
$IDXX Insider Sale: $2.1M of stock sold by Williams Michael J Phd on May 7, 2012 http://stks.co/3kJV
about 21 days ago by MarketBrief
about 21 days ago by MarketBrief
$IDXX http://stks.co/3jZd approaching breakout point, entry above 90... http://stks.co/3jZe
about 21 days ago by TraderHR
about 21 days ago by TraderHR
$IDXX - Still long @ $88.49. Moved Trailing Stop up to $82.56 from the Initial Stop of $80.85 - http://stks.co/3bz8
about 28 days ago by TraderFoxxx
about 28 days ago by TraderFoxxx
UPDATE: Feltl and Company Reiterates Hold Rating, Raises PT for IDEXX Laboratories
Apr 23, 9:32AM Benzinga
Apr 23, 9:32AM Benzinga
Leerink Swann Upgrades IDEXX Laboratories (IDXX) to Outperform; Recovering Vet Market
Apr 23, 8:50AM Street Insider
Apr 23, 8:50AM Street Insider
Mid Day Movers (INCY, GSK, IDXX, PPHM, AMRN, EXEL) http://stks.co/3RgB $INCY $GSK $IDXX $PPHM $AMRN $EXEL
about 39 days ago by retirementplanningzone
about 39 days ago by retirementplanningzone
IDEXX Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Apr 20, 3:25PM Seeking Alpha
Apr 20, 3:25PM Seeking Alpha
News related to $IDXX, currently +0.8% since open: 'Idexx Labs boosts outlook after 1Q profit rises' http://stks.co/3RCx
about 40 days ago by TradeBot
about 40 days ago by TradeBot
$IDXX is -5.1% down since open on unusual high volume and -5.8% down since close.
about 40 days ago by TradeBot
about 40 days ago by TradeBot
Listen to $IDXX Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3Qrp
about 40 days ago by earningscast
about 40 days ago by earningscast
$IDXX http://stks.co/3PBs symmetrical triangle formation http://stks.co/3PBt
about 41 days ago by TraderHR
about 41 days ago by TraderHR
$IDXX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3760
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
Trade Signal-New $IDXX BuyToOpen @ 88.49 Limit w/80.85 Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/d7hbd8f
about 99 days ago by TraderFoxxx
about 99 days ago by TraderFoxxx
Weekly. Rejected at R line & back inside the upper BB. $IDXX http://chart.ly/mhehb7m
about 121 days ago by 1nvestor
about 121 days ago by 1nvestor
IDEXX Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Jan 27, 11:48AM Seeking Alpha
Jan 27, 11:48AM Seeking Alpha
Listen to $IDXX Q4 2011 earnings call (EPS 0.67 vs est 0.63) - live at 09:00 AM, ondemand after - http://stks.co/27ip
about 124 days ago by earningscast
about 124 days ago by earningscast
Idexx Labs (IDXX) Tops Q4 EPS by 1c; Raises Lower-End of FY12 EPS Outlook
Jan 27, 7:03AM Street Insider
Jan 27, 7:03AM Street Insider
$IDXX Insider Sale: $1.2M of stock sold by Jonathan Ayers (Director Chairman, President & Ceo) on January 4, 2012 http://stks.co/1oCu
about 145 days ago by MarketBrief
about 145 days ago by MarketBrief
$IDXX Insider Sale: $1.2M of stock sold by Jonathan Ayers (Director Chairman, President & Ceo) on January 4, 2012 http://stks.co/1mox
about 146 days ago by MarketBrief
about 146 days ago by MarketBrief
$IDXX Insider Sale: $1.1M of stock sold by Jonathan Ayers (Director Chairman, President & Ceo) on December 19, 2011 http://stks.co/1cpR
about 161 days ago by MarketBrief
about 161 days ago by MarketBrief
$IDXX Insider Buy: $485K of stock bought by Robert Murray (Director) on December 16, 2011 http://stks.co/1cpL
about 162 days ago by MarketBrief
about 162 days ago by MarketBrief
$IDXX Insider Sale: $1.1M of stock sold by Jonathan Ayers (Director Chairman, President & Ceo) on November 17, 2011 http://stks.co/1CDU
about 194 days ago by MarketBrief
about 194 days ago by MarketBrief
Okay, so what's the news here that isn't public? Up 6% or so on no news with huge volume... $IDXX
about 195 days ago by dinosaurtrader
about 195 days ago by dinosaurtrader
$IDXX 200 Day SMA Cross - Price crossed above 200 day SMA (76.3453). Confirmed by volume.
about 195 days ago by TradeIdeasQuant
about 195 days ago by TradeIdeasQuant
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IDXX | 87.02 | +0.90 | +1.05% | 4.741B |
| IDX | 25.79 | +0.54 | +2.14% | |
| IDTI | 5.58 | +0.06 | +1.09% | 780.47M |
| IBM | 196.46 | +2.16 | +1.11% | 225.13B |
| IBKR | 14.43 | +0.05 | +0.35% | 655.44M |
| IBKC | 49.38 | +0.54 | +1.11% | 1.436B |
| IBI | 25.08 | +7.14 | +39.80% | 566.90M |
| IACI | 45.83 | +1.10 | +2.46% | 3.635B |
| HZO | 10.00 | +0.54 | +5.71% | 221.65M |
| HYGS | 5.60 | +0.00 | +0.00% | 37.02M |